Health
(36 articles)
Kennedy posts vaccine misinformation, spars on social media amid measles deaths
Kennedy has blamed others for declining vaccination rates, and downplayed the dangers of measles.

On the fence about a statin? In borderline cases, calcium scans could be a tiebreaker
The increasingly popular coronary artery calcium scan is helpful in guiding statin use in only a small share of cases, new studies find.

STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatment
The FDA has approved a life-extending treatment for advanced pancreatic cancer — the first such therapy to attack a genetic cause of the highly lethal malignancy.

STAT+: Key data on a new class of cardio drugs are coming
GSK's shingles vaccine, new financial investment in women's health, and more biotech news from The Readout

STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in drug discovery, and other health AI news.

Even at big companies, health care costs are increasing
Two U.S. measles deaths, the profit motive for women's health, and more Morning Rounds news today

STAT+: Pharmalittle: We’re reading about a GSK shingles shot, U.S. employers dropping GLP-1 coverage, and more
About 14% of employers in the U.S. have already or plan to drop coverage of GLP-1 drugs in 2027, as companies see rising health care costs

Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ shows
Oxford researchers call shingles shot first vaccine protecting both heart and brain. Lower heart disease risk follows study showing reduced dementia risk.

Opinion: Medical aid in dying and the burden of choosing to live
“Once medical aid in dying becomes available, the status quo changes,” writes Monika Piotrowska.

Opinion: Many post-Dobbs abortion fears have not come to pass. What does that mean for advocates?
Opposition to abortion restrictions should focus on values, not statistics, writes David N. Hackney, author of “Impossible Choices.”

STAT+: When it comes to women’s health, money talks
Women's health experts suggest a 'reverse pitch' approach to endometriosis, osteoporosis, and autoimmune treatments, stressing the profit potential.

STAT+: New treatments for common cardiovascular risk factor near the market, with billions at stake
High cholesterol can be managed with medicine, but high Lp(a) levels, another common cardiovascular risk, cannot. Drugmakers are hoping to change that.
